These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7426024)
1. Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes. Yamazoe Y; Ishii K; Yamaguchi N; Kamataki T; Kato R Biochem Pharmacol; 1980 Aug; 29(16):2183-8. PubMed ID: 7426024 [No Abstract] [Full Text] [Related]
2. N-Hydroxylation of arylamides by the rat and guinea pig. Evidence for substrate specificity and participation of cytochrome P1-450. Gutmann HR; Bell P Biochim Biophys Acta; 1977 Jun; 498(1):229-43. PubMed ID: 884151 [No Abstract] [Full Text] [Related]
3. Pseudoenzymatic reduction of N-hydroxy-2-acetylaminofluorene to 2-acetylaminofluorene mediated by cytochrome P450. Kitamura S; Takekawa K; Sugihara K; Tatsumi K; Ohta S Carcinogenesis; 1999 Feb; 20(2):347-50. PubMed ID: 10069476 [TBL] [Abstract][Full Text] [Related]
5. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide. Chow YM; Gutmann HR; Kaplan E Biochem Pharmacol; 1981 Jun; 30(11):1253-61. PubMed ID: 7271824 [No Abstract] [Full Text] [Related]
6. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide. Kaneda S; Seno T; Takeishi K J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527 [TBL] [Abstract][Full Text] [Related]
7. Microsomal metabolism of arylamides by the rat and guinea pig--I. Oxidation of N-3-fluorenylacetamide at carbon-atom-9--a major metabolic reaction. Kaplan E; Gutmann HR; Emory TH Biochem Pharmacol; 1978; 27(11):1581-9. PubMed ID: 697900 [No Abstract] [Full Text] [Related]
8. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Wirth PJ; Alewood P; Calder I; Thorgeirsson SS Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016 [TBL] [Abstract][Full Text] [Related]
9. Effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on the cellular levels of epoxide hydratase, cytochrome P-450b, and NADPH-cytochrome c (P-450) oxidoreductase messenger ribonucleic acids. Gonzalez FJ; Samore M; McQuiddy P; Kasper CB J Biol Chem; 1982 Sep; 257(18):11032-6. PubMed ID: 6809765 [No Abstract] [Full Text] [Related]
10. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide. Hinson JA; Andrews LS; Gillette JR Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868 [No Abstract] [Full Text] [Related]
11. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats. Blanck A; Wicksell L; Eriksson LC Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P-450-dependent nicotine oxidation by liver microsomes of guinea pigs. Immunochemical evidence with antibody against phenobarbital-inducible cytochrome P-450. Nakayama H; Nakashima T; Kurogochi Y Biochem Pharmacol; 1985 Jul; 34(13):2281-6. PubMed ID: 4015676 [TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats. Schut HA; Thorgeirsson SS Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509 [No Abstract] [Full Text] [Related]
14. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation. Stout DL; Baptist JN; Matney TS; Shaw CR Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro of 2-acetylaminofluorene and 2-acetylaminofluoren-9-one by hepatic enzymes. Lenk W; Rosenbauer-Thilmann R Xenobiotica; 1993 Mar; 23(3):241-57. PubMed ID: 8498087 [TBL] [Abstract][Full Text] [Related]
16. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982 [No Abstract] [Full Text] [Related]
17. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396 [TBL] [Abstract][Full Text] [Related]
18. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes. Noshiro M; Harada N; Omura T J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192 [No Abstract] [Full Text] [Related]
19. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin by guinea pig liver microsomal enzymes. Vaught JB; Glowinski IB; King CM Carcinogenesis; 1985 Apr; 6(4):495-9. PubMed ID: 2859126 [TBL] [Abstract][Full Text] [Related]
20. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Kitamura S; Sugihara K; Tatsumi K Biochem Mol Biol Int; 1994 Dec; 34(6):1197-203. PubMed ID: 7696992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]